Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Has results × Lupus Nephritis × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 861 Carcinoma, Non-Small-Cell Lung 630 Prostatic Neoplasms 505 Multiple Myeloma 432 Neoplasms 421 Leukemia, Myeloid, Acute 371 Lymphoma 352 Leukemia 334 Melanoma 332 Neoplasm Metastasis 320 Lung Neoplasms 307 Leukemia, Lymphocytic, Chronic, B-Cell 300 Lymphoma, Non-Hodgkin 298 Colorectal Neoplasms 278 Ovarian Neoplasms 262 Pancreatic Neoplasms 245 Recurrence 237 Precursor Cell Lymphoblastic Leukemia-Lymphoma 237 Myelodysplastic Syndromes 229 Glioblastoma 209 Hodgkin Disease 197 Lymphoma, Large B-Cell, Diffuse 194 Lymphoma, Follicular 194 Brain Neoplasms 193 Carcinoma, Renal Cell 188 Head and Neck Neoplasms 182 Squamous Cell Carcinoma of Head and Neck 179 Lymphoma, Mantle-Cell 170 Sarcoma 156 Fallopian Tube Neoplasms 138

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00447265 2013-02-12

Etanercept for the Treatment of Lupus Nephritis

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 2 Terminated

1 enrolled 15 charts

Lupus Nephritis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡